Such effects have also been confirmed in human subjects and leptin resistant mice where elevated lipids or TNF-α have been associated with obesity, insulin resistance and cardiovascular complications [39,40,41], suggesting that adipose tissue inflammation and obesity are implicated in the development of T2D. Here, LEP is linked to obesity disorder.